Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of Cefditoren Pivoxil Dimer ensuring high purity. Reliable supply chain partner for pharmaceutical intermediates and impurity standards.
Novel patent CN109776462A offers high-purity 2,5-dicyanofuran via biomass route. Significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN103224963A reveals a marine strain method for high-purity chiral amines. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable biocatalysis.
Novel synthesis process for ethyl 2 3 dicyanopropionate offers high yield and reduced waste. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Novel 5-step route for Ozanimod intermediates reduces cost and improves safety. Ideal for API intermediates manufacturing and supply chain optimization.
Novel Grignard-based synthesis offers scalable production. Reduces heavy metal reliance and simplifies purification for reliable supply chain integration.
Patent CN101203614A reveals a novel EDTA-complexed enzymatic resolution for high-purity S-escitalopram, offering scalable cost reduction in API manufacturing.
Novel process using chloroacetyl chloride reduces costs and improves stability for cefathiamidine production. Ideal for API manufacturers seeking efficient supply chains.
Novel patent CN110452277A details improved niacinamide ribose synthesis. Higher yield, purity, and reduced impurities for reliable supply chain partners.
Novel two-step synthesis of lithocholic acid from hyodesoxycholic acid offers high yield and scalable production for pharmaceutical intermediate supply chains globally.
Patent CN112481319A reveals a green enzymatic route for carbamate synthesis, offering high purity and cost reduction in pharmaceutical intermediates manufacturing without toxic phosgene.
Novel macroporous resin purification enhances cefazolin acid purity and yield while reducing solvent usage for scalable pharmaceutical intermediate manufacturing.
Patent CN109608323B reveals a copper-catalyzed route for beta-trifluoromethyl-beta-hydroxy cyclohexanones, offering high yields and scalable pharma intermediate manufacturing.
Patent CN105669548B enables mild manganese-catalyzed oxidation. Delivers high-purity pharmaceutical intermediates with reduced costs and scalable green manufacturing processes.
Novel patent CN103012240B enables scalable atorvastatin calcium production with improved safety and cost efficiency for global pharmaceutical supply chains.
Advanced HCl-based recrystallization method ensures >99.5% purity and >90% yield, offering a reliable supply chain solution for oncology drug manufacturers.
Advanced one-pot catalytic synthesis for high-purity pharmaceutical intermediates. Reduces waste and cost for Vonoprazan production supply chains.
Patent CN113861240A reveals novel trifluoromethyl diphenyl methyl phosphine iodide synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN107011354B reveals a high-purity AgNO3/SOCl2 nitration route for 5-ISMN, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1942476A details enzymatic acylation of rapamycin. Offers high yield, mild conditions, and eliminates heavy metal catalysts for pharmaceutical intermediates.